Advertisement
Nanomedicine
Subscribe to Nanomedicine

The Lead

Nanoparticles infiltrate, kill cancer cells from within

November 24, 2014 11:06 am | by Melanie Titanic-Schefft, Univ. of Cincinnati | News | Comments

Conventional treatment seeks to eradicate cancer cells by drugs and therapy delivered from outside the cell, which may also affect (and potentially harm) nearby normal cells. In contrast to conventional cancer therapy, a Univ. of Cincinnati team has developed several novel designs for iron-oxide based nanoparticles that detect, diagnose and destroy cancer cells using photo-thermal therapy (PTT).

Biochemists build largest synthetic molecular “cage” ever

November 19, 2014 10:26 am | by Stuart Wolpert, Univ. of California, Los Angeles | News | Comments

Univ. of California, Los Angeles biochemists have created the largest-ever protein that self-...

Two sensors in one

November 18, 2014 8:10 am | by Anne Trafton, MIT News Office | News | Comments

Massachusetts Institute of Technology chemists have developed new nanoparticles that can...

Bio-inspired bleeding control

November 13, 2014 4:12 pm | by Sonia Fernandez, Univ. of California, Santa Barbara | News | Comments

Stanching the free flow of blood from an injury remains a holy grail of clinical medicine....

View Sample

FREE Email Newsletter

Regulatory, scientific complexity of generic nanodrugs could delay savings for patients

November 13, 2014 8:07 am | by American Chemical Society | News | Comments

Nanomedicine is offering patients a growing arsenal of therapeutic drugs for a variety of diseases, but often at a cost of thousands of dollars a month. Generics could substantially reduce the price tag for patients—if only there were a well-defined way to make and regulate them. An article in Chemical & Engineering News (C&EN) details the challenges on the road to generic nanodrugs.

Cancer-killing nanodaisies

November 12, 2014 8:31 am | by Alastair Hadden, North Carolina State Univ. | Videos | Comments

North Carolina State Univ. researchers have developed a potential new weapon in the fight against cancer: a daisy-shaped drug carrier that’s many thousands of times smaller than the period at the end of this sentence. Once injected into the bloodstream, millions of these “nanodaisies” sneak inside cancer cells and release a cocktail of drugs to destroy them from within.

Microbubbles can improve stroke treatment

November 6, 2014 10:25 am | by Charlie Feigenoff, Univ. of Virginia | News | Comments

Univ. of Virginia biomedical engineers are building an entire technology around tiny, microscopic bubbles– a technology that has the potential to play an important role in diagnosing as well as treating disease like stroke and cancer.     

Advertisement

Technique turns antibodies into highly tuned nanobodies

November 3, 2014 7:53 am | by Zach Veilleux, The Rockefeller Univ. | News | Comments

Antibodies, in charge of recognizing and homing in on molecular targets, are among the most useful tools in biology and medicine. Nanobodies—antibodies’ tiny cousins—can do the same tasks, for example marking molecules for research or flagging diseased cells for destruction. But, thanks to their comparative simplicity nanobodies offer the tantalizing prospect of being much easier to produce.

Heart-therapy researchers develop nanobullet drug delivery system

October 31, 2014 9:52 am | News | Comments

Stanford Univ. School of Medicine researchers have developed a new formula for delivering the therapeutic peptide apelin to heart tissue for treatment of hypertrophy, a hereditary disease commonly attributed to sudden death in athletes. The nanoscale delivery system, which dramatically increases the peptide’s stability, shows promise for treating heart disease in humans, the researchers said.

Tiny nanopores make big impact

October 30, 2014 8:05 am | by Anne M. Stark, Lawrence Livermore National Laboraotry | News | Comments

A team led by the Lawrence Livermore National Laboratory scientists has created a new kind of ion channel consisting of short carbon nanotubes, which can be inserted into synthetic bilayers and live cell membranes to form tiny pores that transport water, protons, small ions and DNA. These carbon nanotube “porins” have significant implications for future health care and bioengineering applications.

Implantable device remotely releases therapeutic drugs, on Earth or in orbit

October 24, 2014 10:28 am | News | Comments

Houston Methodist Research Institute scientists will receive about $1.25 million from the Center for the Advancement of Science in Space to develop an implantable, nanochannel device that delivers therapeutic drugs at a rate guided by remote control. The device's effectiveness will be tested aboard the International Space Station and on Earth's surface.

Scientists to use tiny particles to fight big diseases

October 23, 2014 12:49 pm | Videos | Comments

A group of scientists in Florida have combined medicine and advanced nanotechnological engineering to create a smarter, more targeted therapy that could overcome the most lethal gynecologic cancer. The technology involves combining Taxol, a chemotherapy drug, with magneto-electric nanoparticles that can penetrate the blood-brain barrier.

Advertisement

Starfish shell-mimicking crystals could advance 3-D printing pills

October 21, 2014 8:19 am | by Nicole Casal Moore, Univ. of Michigan | News | Comments

In a design that mimics a hard-to-duplicate texture of starfish shells, Univ. of Michigan engineers have made rounded crystals that have no facets. The team calls the crystals "nanolobes". The nanolobes' shape and the way they're made have promising applications. The geometry could potentially be useful to guide light in advanced LEDs, solar cells and non-reflective surfaces.

Study reveals optimal particle size for anticancer nanomedicines

October 16, 2014 8:10 am | News | Comments

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. Understanding the interdependency of physiochemical properties of nanomedicines, in correlation to their biological responses and functions, is crucial for their further development of as cancer-fighters.

Is copper prostate cancer’s Kryptonite?

October 15, 2014 7:41 am | by Duke Medicine News and Communications | News | Comments

Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is an essential element in the body. But such avarice may be a fatal weakness. Researchers at Duke Medicine have found a way to kill prostate cancer cells by delivering a trove of copper along with a drug that selectively destroys the diseased cells brimming with the mineral, leaving non-cancer cells healthy.

All that glitters is...slimy? Gold nanoparticles measure snot stickiness

October 13, 2014 10:40 am | News | Comments

Some people might consider mucus an icky bodily secretion best left wrapped in a tissue, but to a group of researchers in North Carolina, snot is an endlessly fascinating subject. The team has developed a way to use gold nanoparticles and light to measure the stickiness of the slimy substance that lines our airways. The new method could help doctors better monitor and treat lung diseases such as cystic fibrosis.

Bio-inspired “nano-cocoons” offer targeted drug delivery against cancer

October 13, 2014 8:39 am | by Matt Shipman, North Carolina State Univ. | News | Comments

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The new system is DNA-based, which means it is biocompatible and less toxic to patients than systems that use synthetic materials.

Advertisement

Charged graphene gives DNA a stage to perform molecular gymnastics

October 10, 2014 8:12 am | by Liz Ahlberg, Physical Sciences Editor, Univ. of Illinois, Urbana-Champaign | News | Comments

When Illinois researchers set out to investigate a method to control how DNA moves through a tiny sequencing device, they didn’t know they were about to witness a display of molecular gymnastics. Fast, accurate and affordable DNA sequencing is the first step toward personalized medicine.

“Stealth” nanoparticles could improve cancer vaccines

October 2, 2014 8:01 am | News | Comments

Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven’t worked that well. Now, scientists have developed a new way to deliver vaccines that successfully stifled tumor growth when tested in laboratory mice. And the key is in the vaccine’s unique stealthy nanoparticles.

Magnetic field opens and closes nanovesicle

September 24, 2014 9:18 am | Videos | Comments

Researchers in the Netherlands have managed to open nanovesicles in a reversible process and close them using a magnet. Previously, these vesicles had been “loaded” with a drug and opened elsewhere using a chemical process, such as osmosis. The magnetic method, which is repeatable, is the first to demonstrate the viability of another method.

Nanotubes help healing hearts keep the beat

September 23, 2014 2:58 pm | Videos | Comments

A Rice Univ. team led by bioengineer Jeffrey Jacot and chemical engineer and chemist Matteo Pasquali have created new pediatric heart-defect patches infused with conductive single-walled carbon nanotubes that allow electrical signals to pass unhindered. The nanotubes overcome a limitation of current patches in which pore walls hinder the transfer of electrical signals between cardiomyocytes, the heart muscle’s beating cells.

Researcher’s nanoparticle key to new malaria vaccine

September 4, 2014 11:26 am | by Colin Poitras, UConn | News | Comments

A self-assembling nanoparticle designed by a Univ. of Connecticut (UConn) professor is the key component of a potent new malaria vaccine that is showing promise in early tests. For years, scientists trying to develop a malaria vaccine have been stymied by the malaria parasite’s ability to transform itself and “hide” in the liver and red blood cells of an infected person to avoid detection by the immune system.

Handheld scanner could aid complete removal of brain tumors

September 3, 2014 1:09 pm | News | Comments

Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them, and for leading to a dire prognosis for patients. But scientists are developing a new way to try to root out malignant cells during surgery so fewer or none get left behind to form new tumors. The technology relies on a Raman scanner that can read injected nanoprobes.

New DARPA program aimed at developing customized therapies

August 28, 2014 9:11 am | News | Comments

DARPA’s new Electrical Prescriptions (ElectRx) program was among the initiatives the White House highlighted this week as President Barack Obama addressed the need for new and more effective strategies for improving the health of service members, veterans and others. ElectRx goes beyond medication, aiming to explore neuromodulation of organ functions to help the human body heal itself.

Living organ grown from lab-created cells

August 25, 2014 2:25 pm | Videos | Comments

Laboratory-grown replacement organs have moved a step closer with the completion of a new study. Scientists have grown a fully functional organ from transplanted laboratory-created cells in a living animal for the first time. They have created a thymus, an organ next to the heart that produces immune cells known as T cells that are vital for guarding against disease.

Breakthrough understanding of biomolecules could lead to new, better drugs

August 25, 2014 9:09 am | by Marcia Goodrich, Michigan Technological Univ. | News | Comments

There’s a certain type of biomolecule built like a nano-Christmas tree. Called a glycoconjugate, it’s many branches are bedecked with sugary ornaments. It’s those ornaments that get all the glory. That’s because, according to conventional wisdom, the glycoconjugate’s lowly “tree” basically holds the sugars in place as they do the important work of reacting with other molecules.

Vault nanoparticles show promise for cancer treatment, potential HIV cure

August 22, 2014 9:47 am | by Shaun Mason, Univ. of California, Los Angeles | News | Comments

A multidisciplinary team of scientists from the Univ. of California, Los Angeles and Stanford Univ. has used a naturally occurring nanoparticle called a vault to create a novel drug delivery system that could lead to advances in the treatment of cancer and HIV. Their findings could lead to cancer treatments that are more effective with smaller doses and to therapies that could potentially eradicate the HIV virus.

Immune cells get cancer-fighting boost from nanomaterials

August 14, 2014 9:00 am | by Rase McCry, Yale Univ. | News | Comments

Scientists at Yale Univ. have developed a novel cancer immunotherapy that rapidly grows and enhances a patient’s immune cells outside the body using carbon nanotube-polymer composites; the immune cells can then be injected back into a patient’s blood to boost the immune response or fight cancer.

Nanotech invention improves effectiveness of the “penicillin of cancer”

August 14, 2014 8:01 am | by Jared Sagoff, Argonne National Laboratory | News | Comments

By combining magnetic nanoparticles with one of the most common and effective chemotherapy drugs, Argonne National Laboratory researchers have created a way to deliver anti-cancer drugs directly into the nucleus of cancer cells. They have created nano-sized bubbles, or “micelles,” that contain magnetic nanoparticles of iron oxide and cisplatin, a conventional chemotherapy drug also known as “the penicillin of cancer.”

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading